Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 17 studies | 30% ± 13% | |
brain | 16 studies | 37% ± 17% | |
peripheral blood | 11 studies | 20% ± 3% | |
intestine | 7 studies | 32% ± 17% | |
kidney | 7 studies | 22% ± 8% | |
eye | 7 studies | 27% ± 10% | |
adipose | 5 studies | 25% ± 11% | |
pancreas | 4 studies | 37% ± 19% | |
placenta | 4 studies | 32% ± 8% | |
uterus | 3 studies | 30% ± 12% | |
liver | 3 studies | 24% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 15568.04 | 258 / 258 | 100% | 630.96 | 230 / 230 |
ovary | 100% | 15275.66 | 180 / 180 | 100% | 228.78 | 430 / 430 |
brain | 100% | 18800.60 | 2637 / 2642 | 100% | 164.53 | 705 / 705 |
thymus | 100% | 10744.30 | 652 / 653 | 100% | 315.67 | 603 / 605 |
skin | 100% | 10223.67 | 1807 / 1809 | 99% | 267.47 | 469 / 472 |
prostate | 100% | 11580.13 | 245 / 245 | 99% | 154.22 | 498 / 502 |
kidney | 100% | 9544.34 | 89 / 89 | 99% | 156.96 | 893 / 901 |
uterus | 100% | 11859.88 | 170 / 170 | 99% | 230.21 | 454 / 459 |
esophagus | 100% | 8485.06 | 1445 / 1445 | 99% | 113.92 | 181 / 183 |
pancreas | 100% | 6446.34 | 328 / 328 | 99% | 189.74 | 176 / 178 |
lung | 100% | 15740.93 | 578 / 578 | 99% | 289.71 | 1142 / 1155 |
breast | 100% | 11531.98 | 459 / 459 | 98% | 154.77 | 1100 / 1118 |
intestine | 100% | 9501.13 | 966 / 966 | 98% | 108.03 | 515 / 527 |
stomach | 100% | 7831.24 | 359 / 359 | 98% | 115.95 | 279 / 286 |
bladder | 100% | 9788.52 | 21 / 21 | 97% | 169.56 | 489 / 504 |
liver | 100% | 5220.36 | 225 / 226 | 97% | 103.69 | 394 / 406 |
adipose | 100% | 13033.39 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 288.03 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 172.17 | 29 / 29 |
spleen | 100% | 16478.90 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 154.32 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 81.58 | 1 / 1 |
blood vessel | 100% | 13936.44 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 9473.99 | 852 / 861 | 0% | 0 | 0 / 0 |
muscle | 97% | 4596.80 | 777 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 85% | 4246.88 | 789 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002376 | Biological process | immune system process |
GO_0014902 | Biological process | myotube differentiation |
GO_0006259 | Biological process | DNA metabolic process |
GO_0006954 | Biological process | inflammatory response |
GO_1900015 | Biological process | regulation of cytokine production involved in inflammatory response |
GO_0031901 | Cellular component | early endosome membrane |
GO_0043202 | Cellular component | lysosomal lumen |
GO_0000139 | Cellular component | Golgi membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0031902 | Cellular component | late endosome membrane |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0045145 | Molecular function | single-stranded DNA 5'-3' DNA exonuclease activity |
GO_0005515 | Molecular function | protein binding |
GO_0004630 | Molecular function | phospholipase D activity |
Gene name | PLD3 |
Protein name | 5'-3' exonuclease PLD3 (EC 3.1.16.1) (Choline phosphatase 3) (Phosphatidylcholine-hydrolyzing phospholipase D3) (Phospholipase D3) Phospholipase D family member 3 5'-3' exonuclease PLD3 (EC 3.1.16.1) (Choline phosphatase 3) (HindIII K4L homolog) (Hu-K4) (Phosphatidylcholine-hydrolyzing phospholipase D3) (Phospholipase D3) (PLD 3) |
Synonyms | |
Description | FUNCTION: 5'->3' DNA exonuclease which digests single-stranded DNA (ssDNA) . Regulates inflammatory cytokine responses via the degradation of nucleic acids, by reducing the concentration of ssDNA able to stimulate TLR9, a nucleotide-sensing receptor in collaboration with PLD4 (By similarity). May be important in myotube formation . Plays a role in lysosomal homeostasis . Involved in the regulation of endosomal protein sorting . . |
Accessions | ENST00000600948.5 ENST00000392032.6 ENST00000700619.1 ENST00000700637.1 A0A8V8TQH4 ENST00000599353.1 M0QX99 ENST00000409735.9 ENST00000700633.1 ENST00000700620.1 ENST00000596682.5 M0QX50 ENST00000409587.5 ENST00000700630.1 ENST00000492243.1 ENST00000409419.5 M0R3G9 M0QY94 ENST00000700623.1 ENST00000700628.1 ENST00000599685.5 ENST00000598962.5 A0A0A0MS28 M0R2E7 M0R2W7 A0A8V8TRD4 ENST00000356508.9 ENST00000602131.5 ENST00000486134.1 ENST00000700634.1 A0A8V8TQH6 ENST00000700638.1 M0QYJ4 ENST00000359274.5 ENST00000700626.1 Q8IV08 ENST00000700624.1 M0R1F7 ENST00000700631.1 ENST00000700616.1 ENST00000700632.1 A0A8V8TPY8 ENST00000409281.5 ENST00000700621.1 ENST00000700617.1 E2QRG1 ENST00000594908.5 M0QZK2 ENST00000700625.1 ENST00000700618.1 |